Back to Kalehua Capital Management LLC
Kalehua Capital Management LLC
Q3 2026 13F filing
Updated 9 days ago22 disclosed positions worth $132.4M
Portfolio value
$132.4M
Total holdings
22
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-13
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | M VERADERMICS INC | $17.7M | 145.7K | 13.34% | — |
| 2 | ? N/A EA SERIES TRUST | $17.6M | 148.5K | 13.28% | — |
| 3 | K KORSANA BIOSCIENCES INC | $14.2M | 442.7K | 10.70% | — |
| 4 | ? N/A X4 PHARMACEUTICALS INC | $10.8M | 3.72M | 8.15% | — |
| 5 | A ACLARIS THERAPEUTICS INC | $9.6M | 1.83M | 7.28% | — |
| 6 | ? N/A SURROZEN INC | $9.2M | 286.1K | 6.95% | — |
| 7 | I INHIBIKASE THERAPEUTICS INC | $7.9M | 3.82M | 5.93% | — |
| 8 | S SEPTERNA INC | $7.6M | 194.5K | 5.75% | — |
| 9 | B BETTERLIFE PHARMA INC | $6.7M | 27.71M | 5.04% | — |
| 10 | O OBSIDIAN THERAPEUTICS INC | $5.7M | 416.6K | 4.32% | — |
| 11 | I INFLARX NV | $5.3M | 2.92M | 3.97% | — |
| 12 | K KORRO BIO, INC | $4.7M | 473.6K | 3.54% | — |
| 13 | ? N/A ATTOVIA THERAPEUTICS INC | $3.4M | 200.0K | 2.59% | — |
| 14 | ? N/A DAMORA THERAPEUTICS INC | $3M | 139.0K | 2.23% | — |
| 15 | Q UNIQURE NV | $1.9M | 79.4K | 1.45% | — |
| 16 | G GOSSAMER BIO INC | $1.7M | 139.4K | 1.25% | — |
| 17 | M MILESTONE PHARMACEUTICALS IN | $1.4M | 1.65M | 1.08% | — |
| 18 | L LEONABIO INC | $1.4M | 393.7K | 1.06% | — |
| 19 | R ATRIUM THERAPEUTICS INC | $933K | 112.7K | 0.70% | — |
| 20 | T INSTIL BIO INC | $721K | 99.6K | 0.54% | — |
| 21 | A ATYR PHARMA INC | $554K | 1.83M | 0.42% | — |
| 22 | K KAZIA THERAPEUTICS LTD | $537K | 56.0K | 0.41% | — |